Effects of Oil and Dry Neonatal Massage on Hyperbilirubinemia and Comfort

October 11, 2024 updated by: meral güven
The need for infant massage may come to the forefront as a part of routine care in the neonatal intensive care unit to reduce high bilirubin levels in newborns and to reduce the need for phototherapy treatment. This study was planned to investigate the effects of oily and dry neonatal massage on hyperbilirubinemia and comfort.

Study Overview

Detailed Description

Hyperbilirubinemia is a common disease affecting newborns. It is a self-limiting condition, but if not properly monitored and managed, it can cause permanent neurological disorders. Hyperbilirubinemia affects approximately 8-11% of newborns and accounts for 75% of hospitalizations in the first weeks of life. Physiological jaundice occurs in newborns within the first 24-72 hours after birth; it is at its highest level on days 3-4, begins to decrease on days 5-7 and disappears completely on days 10-14, and in premature babies, it occurs after 48 hours and can take up to 4 weeks to completely resolve. Jaundice that occurs within the first 24 hours is pathological jaundice. High bilirubin levels can cause kernicterus, which can lead to serious neurological damage if not diagnosed and treated early. This condition has a 75% probability of death in infants and can cause neurological sequelae in 80% of survivors. Different treatment methods are used to reduce bilirubin levels. Frequently used methods are; exchange transfusion, phototherapy and drug therapy. Phototherapy is one of the most frequently used methods in the treatment of hyperbilirubinemia. Phototherapy has many complications such as damage to the retina and reproductive organs, dehydration in the body, skin rashes, watery stools and bronze baby syndrome. Recently, research has been conducted on different treatment approaches and new applications to manage neonatal hyperbilirubinemia and shorten the hospitalization period. It has been stated that massage and bath applications reduce bilirubin levels in newborns. Massage is the systematic manual stimulation of the soft tissues of the body with movements such as friction, pressing, rolling and touching for therapeutic purposes. Massage, which is one of the oldest healing applications and can be easily applied together with traditional treatments, is the most natural and instinctive tools.Massage in newborns is accepted as a new care method with positive effects.Neonatal massage is not a mechanical routine, but a simple, cheap and effective technique to support newborn development and to ensure that parents establish eye contact with their babies. Massage is a new, easy to apply and alternative method that can be used to reduce bilirubin levels in newborns. Baby massage can help to remove bilirubin from the body by increasing lymph and blood circulation. Massage stimulates bowel movements and causes early defecation. Increased intestinal peristalsis reduces the enterohepatic circulation of bilirubin and accelerates its excretion from the body. Studies have shown that massage significantly increases the frequency of defecation in babies. Baby massage can significantly increase the number of stools by significantly increasing the intestinal stimulation of babies with vagal activity and thus help to remove bilirubin from the body. In the findings of many studies; it has been reported that baby massage is a method that helps to remove bilirubin from the body.

Study Type

Interventional

Enrollment (Actual)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Merkez
      • Iğdır, Merkez, Turkey
        • Igdir University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Being a term (37-42 weeks) newborn.
  • The newborn's postnatal age is between 1st and 28th days
  • The 1st and 5th Apgar score is between 7-10
  • The newborn is fed orally
  • The newborn's birth weight is 2500 grams and above
  • Phototherapy treatment is terminated and followed up
  • Receiving nutritional support for hyperbilirubinemia
  • No health problems other than hyperbilirubinemia
  • Stable general health status
  • Parents' willingness and volunteering to participate in the study constitute the inclusion criteria for the study.

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: control group
Babies in the control group will receive treatment and care according to neonatal intensive care unit procedures. No intervention will be applied.
Experimental: Dry Full Body Massage Group
Unlike the control group, dry whole body massage was applied to the babies who were followed up after completing the phototherapy treatment process.
Applying massage after phototherapy
Experimental: Oil Full Body Massage Group
Unlike the control group, the babies in this group received a full body oil massage. The full body oil massage was applied using pure baby olive oil.
Oil Full Body Massage

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Newborn Comfort Behavior Scale (COMFORTneo)
Time Frame: 9 months
The Newborn Comfort Behavior Scale, developed to determine sedation, need for comfort, pain or distress in infants followed in the NICU, is a five-point Likert-type scale. The five-point Likert-type scale consists of six parameters including alertness, calmness/agitation, respiratory response, crying, body movements, facial tension and muscle tone. In infants receiving mechanical ventilation, the "Respiratory Response" element is taken into account, and in those not receiving mechanical ventilation, the "Crying" element is taken into account.
9 months
Numerical Assessment Scales
Time Frame: 9 months
Numerical Assessment Scales are based on the observation of the researcher. Each item in the scale is scored from 1 to 5 and evaluated over a total score. The lowest score on the scale should be 6 and the highest score should be 30. If the total score obtained from the scale is between 9-13, it means that the newborn is comfortable, and if it is between 14-30, it means that the newborn is in pain or distress and therefore not comfortable.
9 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Collaborators

Investigators

  • Principal Investigator: meral güven, Igdir University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2023

Primary Completion (Actual)

June 30, 2024

Study Completion (Actual)

August 31, 2024

Study Registration Dates

First Submitted

October 5, 2024

First Submitted That Met QC Criteria

October 7, 2024

First Posted (Actual)

October 8, 2024

Study Record Updates

Last Update Posted (Actual)

October 15, 2024

Last Update Submitted That Met QC Criteria

October 11, 2024

Last Verified

October 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

I don't prefer

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Hyperbilirubinemia, Neonatal

Clinical Trials on Dry Full Body Massage

Subscribe